Dispensing error legal change comes into effect

Dispensing error legal change comes into effect

April 16 2018 The amendment to the law which will give a defence to the criminal charge of making...

DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

April 12 2018 Changes introduced in 2013 to manage pharmacy numbers, along with changes to the...

PSNC and NPA lobby for GDPR exemption for small primary care service providers

PSNC and NPA lobby for GDPR exemption for small primary care service providers

March 26 2018 Health organisations are asking that small NHS contractors be exempted from...

GPhC consultants on independent prescribing changes

GPhC consultants on independent prescribing changes

March 22 2018 The initial training and education of pharmacists studying to become independent...

Study questions appropriateness of 28-day prescriptions for long term conditions

Study questions appropriateness of 28-day prescriptions for long term conditions

March 22 2018 Medicine adherence may benefit in long term conditions by issuing prescriptions for...

  • Dispensing error legal change comes into effect

    Dispensing error legal change comes into effect

    Monday, 16 April 2018 14:06
  • DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

    DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

    Thursday, 12 April 2018 11:30
  • PSNC and NPA lobby for GDPR exemption for small primary care service providers

    PSNC and NPA lobby for GDPR exemption for small primary care service providers

    Monday, 26 March 2018 12:28
  • GPhC consultants on independent prescribing changes

    GPhC consultants on independent prescribing changes

    Thursday, 22 March 2018 11:55
  • Study questions appropriateness of 28-day prescriptions for long term conditions

    Study questions appropriateness of 28-day prescriptions for long term conditions

    Thursday, 22 March 2018 11:44

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a RPS building imageAugust 31 2017

The Royal Pharmaceutical Society has commenced a year-long programme to develop guidance around polypharmacy.

 It will be working with a range of stakeholders and has set up a multidisciplinary steering group which will include healthcare professionals and patients. It will also ask for input from royal colleges and professional bodies, expert and specialist groups, patients and practitioners.

Announcing the programme, the Society said that data from around the world “demonstrates that the number of medicines prescribed to individual patients has grown significantly over the last 10-15 years. As the population ages and many people take an increasing number of medicines for multiple long term conditions, polypharmacy has become a key issue in health and social care.”

In addition, it notes that many countries have developed strategies and guidance to address the problems caused by inappropriate polypharmacy, including in Scotland and Wales. “It is therefore right and timely that the Royal Pharmaceutical Society develops guidance for pharmacists, and others working with patients to review their medication needs, so that this work can be done in a patient-centred way using the best evidence and good practice that exists in this field.

“We aim, in the development of this guidance, to build on experience and expertise from across England, Scotland and Wales and complement existing guidance across Great Britain.” The Society intends to give regular updates as the work progresses, and will post the draft guidance online for open consultation and comment before being finalised.

Link:
RPS announcement        

Legal & Policy News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...